Brown University, CureAccelerator Live!, Current Research, Dr. Holder, Drug, Minority/Underserved, Oncology, Rare, Rhode Island Hospital
Repurposing the Prostate Cancer Drug Degarelix to Treat Bladder Cancer Principal Investigator: Dr. Sheldon Holder Condition: Bladder Cancer Research Description: More than 80,000 people are diagnosed with bladder cancer (BC) in the USA each year and roughly 17,000...
Cardio, CureAccelerator Live!, Current Research, Dr. Amorim, Drug, Health Disparities, Minority/Underserved, Neuro, University of California, University of California San Francisco
Testing the Epilepsy Drug Perampanel to Prevent Seizures After Cardiac Arrest Resuscitation Principal Investigator: Dr. Edilberto Amorim Condition: Seizures following cardiac arrest resuscitation Research Description: More than 350,000 Americans have a cardiac arrest...
CureAccelerator Live!, Current Research, Dr. Gordon, Drug, Minority/Underserved, Oncology, Pediatric, Rare, The University of Texas MD Anderson Cancer Center
Enhancing Treatment Response in Recurrent/Metastatic Osteosarcoma with Hydroxychloroquine Principal Investigator: Dr. Nancy Gordon Disease: Osteosarcoma Research Description: Osteosarcoma (OS) is an orphan disease affecting approximately 400 children and adolescents...
Adult, Chicago, CureAccelerator Live!, Current Research, Drug, Loyola University Medical Center, Oncology, Rare, Women's Health
Repurposing the Blood Pressure Drug Minoxidil for the Treatment of Recurrent Chemo-Resistant Ovarian Cancer and Other Gynecological Cancers Principal Investigator: Dr. Margaret Liotta Disease: Ovarian cancer Research Description: Epithelial ovarian cancer is the most...
CureAccelerator Live!, Current Research, Dr. Teng, Drug, Pediatric, Rare, Stanford University, Vascular
Treating Vascular Malformations Using the Cancer Drug Trametinib Principal Investigator: Dr. Joyce Teng Disease: Extracranial arteriovenous malformations Research Description: Extracranial arteriovenous malformation (AVM) is a network of abnormal blood vessels more...
CureAccelerator Live!, Current Research, Dr. Rower, Drug, Ear Nose Throat, Hearing Loss, Infectious Disease, Inner Ear, Pediatric, Rare, University of Utah
Repurposing the Antiviral Drug Valganciclovir to Treat Cytomegalovirus-Induced Hearing Loss Principal Investigator: Dr. Joseph Rower Disease: Hearing loss Research Description: Almost 400 children die each year from congenital cytomegalovirus (cCMV) infections, and...
